Lupin gets tentative FDA green light for generic Natazia tablets

Press enter to search
Close search
Open Menu

Lupin gets tentative FDA green light for generic Natazia tablets

By Sandra Levy - 08/22/2018
Lupin has received the Food and Drug Administration’s tentative approval for Nudovra (estradiol valerate) tablets 3 mg and 1 mg and estradiol valerate and dienogest tablets 2 mg/2 mg and 2 mg/3 mg) tablets, an estrogen/progestin combined oral contraceptive indicated for use by women to prevent pregnancy.

The product, which is a generic version of Bayer HealthCare Pharmaceuticals’ Natazia tablets, had a market value of approximately $31.4 million, according to June 2018 IQVIA data.

Related Topics